It wasn’t long ago since the genome was fully decoded. Now, Israel’s C2i Genomics (see here previously) has teamed up with Tel Aviv’s Sourasky (Ichilov) Medical Center take blood test data and perform whole genome minimal residual disease (MRD) testing to detect recurring cancer early.
https://www.israel21c.org/ai-cancer-startup-collaborates-with-top-israeli-hospital/